Biopharmaceuticals

Viking Therapeutics’ inventory greater than doubles as traders cheer low cost entry to weight-loss-drug craze

We’re spending extra on leisure and journey. These 11 shares will soak it up.

AbbVie lowers first-quarter steerage after closing acquisition ImmunoGen

Amgen’s quarterly outcomes prime expectations regardless of Enbrel gross sales decline

Novartis to bolster its oncology portfolio with acquisition of MorphoSys

Sell AstraZeneca, says UBS, which upgrades European rivals together with GSK

Nvidia dives deeper into AI drug growth with Amgen, Recursion partnerships 

Omega Therapeutics inventory greater than doubles on Novo Nordisk weight problems drug analysis pact

Iovance inventory drops 24% after it halts cancer-drug trial

Fusion Pharma climbs as radiopharmaceutical firm flagged as potential merger goal